Virax Biolabs Group Ltd (VRAX)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Jun 28, 16:00
1.15
-0.01
(-0.86%)
After-Hours: 20:00
Virax Biolabs Group 1 Year Total Returns (Daily): -68.74% for June 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
June 28, 2024 | -68.74% |
June 27, 2024 | -69.77% |
June 26, 2024 | -66.02% |
June 25, 2024 | -63.06% |
June 24, 2024 | -64.17% |
June 21, 2024 | -61.69% |
June 20, 2024 | -57.02% |
June 18, 2024 | -59.93% |
June 17, 2024 | -59.93% |
June 14, 2024 | -63.65% |
June 13, 2024 | -56.87% |
June 12, 2024 | -58.00% |
June 11, 2024 | -61.41% |
June 10, 2024 | -54.59% |
June 07, 2024 | -50.61% |
June 06, 2024 | -48.38% |
June 05, 2024 | -71.92% |
June 04, 2024 | -73.42% |
June 03, 2024 | -73.68% |
May 31, 2024 | -69.87% |
May 30, 2024 | -70.56% |
May 29, 2024 | -77.56% |
May 28, 2024 | -78.29% |
May 24, 2024 | -78.34% |
May 23, 2024 | -80.20% |
Date | Value |
---|---|
May 22, 2024 | -79.92% |
May 21, 2024 | -80.56% |
May 20, 2024 | -79.61% |
May 17, 2024 | -77.07% |
May 16, 2024 | -77.76% |
May 15, 2024 | -77.64% |
May 14, 2024 | -78.61% |
May 13, 2024 | -77.53% |
May 10, 2024 | -77.34% |
May 09, 2024 | -80.83% |
May 08, 2024 | -79.03% |
May 07, 2024 | -79.21% |
May 06, 2024 | -82.13% |
May 03, 2024 | -83.54% |
May 02, 2024 | -84.05% |
May 01, 2024 | -83.82% |
April 30, 2024 | -84.93% |
April 29, 2024 | -84.96% |
April 26, 2024 | -85.00% |
April 25, 2024 | -84.11% |
April 24, 2024 | -84.92% |
April 23, 2024 | -86.29% |
April 22, 2024 | -85.32% |
April 19, 2024 | -87.91% |
April 18, 2024 | -88.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.14%
Minimum
Jul 28 2023
-48.38%
Maximum
Jun 06 2024
-84.52%
Average
-86.14%
Median
Mar 04 2024
1 Year Total Returns (Daily) Benchmarks
Barinthus Biotherapeutics PLC | -37.78% |
Adaptimmune Therapeutics PLC | 6.64% |
Biodexa Pharmaceuticals Plc | -84.23% |
Verona Pharma PLC | -30.35% |
NuCana PLC | -87.13% |